Press Releases

  • Shoshana Levy dies

    Shoshana Levy discovered a family of molecules called tetraspanins, launching a new field of cancer research. She was an active researcher, collaborator and mentor at Stanford Medicine for nearly three decades.

  • Translational research master’s program

    A new Stanford School of Medicine master’s program trains students in taking basic science research findings from the lab to patient care.

  • Gel treatment heals blistering wounds

    Researchers find that a gel tested in patients with a life-threatening blistering skin disease helps wounds heal. The gel — the first topical gene therapy — awaits FDA approval.

  • Possible new way to kill cancer cells

    After finding long, repetitive sequences in the genomes of seven kinds of cancer, researchers at Stanford Medicine and their colleagues developed a molecule that curbed their production.

  • Hepatitis C treatment low

    Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.

  • Predicting preeclampsia from urine, blood

    Biological molecules in urine and gene-activity signals in blood can predict early in pregnancy which women develop preeclampsia, Stanford Medicine researchers found.

  • Stanford hospitals earn top honors

    A leader in U.S. hospital quality ratings has given Stanford Health Care and Stanford Health Care Tri-Valley top grades for safety. Stanford Health Care was also named a top teaching hospital.

  • Stanford Health Care among nation’s top hospitals

    For eighth year running, U.S. News & World Report ranks Stanford Health Care one of the nation’s highest-rated hospitals.

  • ‘Digital human’ helps reduce knee stress

    A computer simulation that relates muscle activation patterns to harmful pressure on the knee helps participants adopt knee-protective strategies as they walk.

  • Improving clinical trial diversity

    The American Heart Association has provided funding to two Stanford Medicine professors to develop ways to diversify enrollment in heart disease clinical trials.


2023 ISSUE 3

Exploring ways AI is applied to health care